MDxHealth S.A.

NASDAQ:MDXH

Medical - Diagnostics & Research

Healthcare
$0.60 -4.45%

-$0.03 today

Market cap
$57.59M
Beta
0.38
P/E (TTM)
-1.0
EPS (TTM)
-$0.58
52W Low $0.40High $5.33

Volume 0.65M

Average 4.27M

MDXH Net Income

Bottom-line profit after all expenses, interest, and taxes.

MDxHealth S.A.NASDAQ: MDXH

Net Income · Q2 FY2026 · quarter ended Jun 2026

Net income remains negative

Q2 FY2026 net income was -$11.53M, compared with -$7.37M a year earlier.

Context

  • Net income amounted to 31.1% of revenue in FY2025, down 11.2 pp from a year earlier.
  • Net income grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 4 analysts of -$25.33M (+24.4%) for the fiscal year ending Dec 2026, a step up from the +12.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
-$11.53M— QoQ
Last fiscal yearDec 2025
-$33.52M+12.0% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-56.4%——
1 year+12.0%+24.4%+12.5 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the income statement

Latest · FY2025
(33.52M) USD
Year-over-year change
+12.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How MDXH compares with its peers on the latest reported figures

  • MDXH's FY2025 net income of -$33.52M is the 5th highest of the 11 companies compared; the peer median is -$47.98M.
  • Its year-over-year change of +12.0% is the 6th highest of 11, against a peer median of +13.2%.
  • Net income amounts to 31.1% of revenue for MDXH, versus a peer median of 52.9%.
MDXH Competitors Peer median
Net Income for MDXH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SNWVSANUWAVE Health, Inc.LTM Mar 2026$16.05M +149.4%—36.2%
ASMBAssembly Biosciences, Inc.LTM Mar 2026-$6.38M +84.0%—9.0%
XGNExagen Inc.LTM Mar 2026-$20.17M -30.0%—29.5%
STXSStereotaxis, Inc.LTM Mar 2026-$21.68M +14.5%—69.5%
MDXHMDxHealth S.A.FY2025-$33.52M +12.0%—31.1%
SIShoulder Innovations, Inc.LTM Mar 2026-$44.08M -164.2%—81.8%
NEONeoGenomics, Inc.LTM Jun 2026-$51.88M +50.1%—6.8%
IMRXImmuneering CorporationLTM Mar 2026-$54.44M +11.9%——
ACRSAclaris Therapeutics, Inc.LTM Mar 2026-$69.66M +46.5%—832.6%
ZURAZura Bio LimitedLTM Mar 2026-$75.43M -31.1%——
QTRXQuanterix CorporationLTM Mar 2026-$104.19M -117.6%—71.9%
Peer median (excluding MDXH) -$47.98M+13.2%—52.9%

Competitors are the stored peer set for MDXH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue22.24M37.05M70.19M90.05M107.88M
Cost of Revenue11.68M17.84M26.26M34.91M43.43M
Gross Profit10.56M19.22M43.93M55.14M64.44M
Gross Margin47.5%51.9%62.6%61.2%59.7%
Research & Development5.59M7.56M6.38M10.55M10.35M
Selling, General & Admin30.22M50.12M59.93M61.4M66.75M
Operating Expenses37.41M57.12M71.26M79.86M79.84M
Depreciation & Amortization3.04M4.91M6.86M8.04M9.21M
EBITDA(24.09M)(36.39M)(30.47M)(22.02M)(14.01M)
EBITDA Margin-108.3%-98.2%-43.4%-24.5%-13.0%
Operating Income(26.84M)(37.9M)(27.33M)(24.72M)(15.4M)
Operating Margin-120.7%-102.3%-38.9%-27.5%-14.3%
Interest Income11K125K1.09M1.08M1.5M
Interest Expense1.88M2.74M5.77M7.63M12.16M
Other Income / Expenses(2.16M)(6.14M)(15.77M)(12.97M)(19.98M)
Income Before Tax(29M)(44.04M)(43.1M)(37.69M)(35.38M)
Pre-Tax Margin-130.4%-118.9%-61.4%-41.9%-32.8%
Income Tax Expense001K382K(1.86M)
Net Income(29M)(44.04M)(43.1M)(38.07M)(33.52M)
Net Margin-130.4%-118.9%-61.4%-42.3%-31.1%
EPS (Basic)(2.38)(2.78)(1.66)(0.78)(0.67)
EPS (Diluted)(2.38)(2.78)(1.66)(1.16)(0.67)
Weighted Avg Shares12.19M15.87M25.91M48.67M50.03M
Weighted Avg Shares (Diluted)12.19M15.87M25.91M48.67M50.03M

MDxHealth S.A.

NASDAQ:MDXH

Intrinsic Alpha fair value

Locked

Current Price

$0.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.